论文部分内容阅读
他达拉非OAD方案治疗良性前列腺增生症的下尿路症状的安全性和有效性:一项多国多中心随机双盲安慰剂对照试验Eur Urol.2011 Aug 12.在前期多项关于他达拉非治疗良性前列腺增生症的下尿路症状(BPH-LUTS)研究的基础上,本研究旨在评估他达拉非用于BPH-LUTS的有效性(包括开始用药阶段)和安全性,以及患者和临床医生对下尿路症
Safety and efficacy of tadalafil OAD regimen in treating lower urinary tract symptoms of benign prostatic hyperplasia: A multinational, multicentre randomized, double-blind, placebo-controlled trial Eur Urol.2011 Aug 12. In a number of previous articles on Tadala Based on a study of lower urinary tract symptoms (BPH-LUTS) in non-treatment of benign prostatic hyperplasia, the purpose of this study was to evaluate the efficacy (including initial dosing phase) and safety of tadalafil in BPH-LUTS as well as in patients And clinicians on the lower urinary tract disease